Jeuveau is an injectable neurotoxin used to temporarily smooth frown lines between the eyebrows. Approved by the FDA in 2019 and manufactured by Evolus Inc., it’s the first injectable neurotoxin designed exclusively for cosmetic use. It works the same way as Botox, blocking nerve signals that cause specific facial muscles to contract, but it’s typically 20 to 30 percent less expensive.
How Jeuveau Works
Jeuveau contains a form of botulinum toxin type A, the same family of proteins found in Botox, Dysport, and Xeomin. When injected into a muscle, the toxin enters nearby nerve endings and blocks the release of acetylcholine, the chemical messenger that tells muscles to contract. Without that signal, the targeted muscles relax, and the overlying skin smooths out.
The process happens in stages. The toxin binds to receptors on the nerve cell surface and gets pulled inside. Once there, it breaks apart a protein called SNAP-25 that nerve cells need to release acetylcholine. With that protein disabled, the nerve can’t communicate with the muscle. The effect isn’t permanent because nerve cells eventually repair themselves and restore normal signaling, which is why results fade after a few months.
What Jeuveau Treats
Jeuveau is FDA-approved for one specific use: moderate to severe glabellar lines, the vertical creases that form between your eyebrows when you frown. These are sometimes called “elevens” because they often appear as two parallel vertical lines. Clinical trials confirmed that a single 20-unit treatment was both safe and effective for softening these lines.
Some providers also use Jeuveau off-label in other areas of the face, such as forehead lines or crow’s feet, following the same principles that guide off-label use of other neurotoxins. However, these uses haven’t been formally studied in Jeuveau-specific trials.
What to Expect During Treatment
A typical Jeuveau session for frown lines involves around 10 to 20 units, split across five small injection points in the muscles between and just above the eyebrows. The procedure takes roughly 10 to 15 minutes and doesn’t require anesthesia, though some providers apply a topical numbing cream. Most people describe the sensation as a brief pinch at each injection site.
Results aren’t immediate. You’ll start noticing smoother skin within a few days, with full effects visible around day 14. One post-hoc analysis found that Jeuveau showed visible improvement as early as day 2 in some patients. The smoothing effect typically lasts three to four months before muscle activity gradually returns and lines begin to reappear. Maintaining results requires follow-up treatments a few times per year.
How Jeuveau Compares to Botox
Jeuveau and Botox are closely related. Both use botulinum toxin type A, both are dosed in the same units, and both treat the same frown lines at the same standard dose of 20 units. In a Phase III clinical study comparing the two head-to-head, Jeuveau-treated patients showed slightly higher response rates at nearly every time point, with an average difference of about 10 percent across all visits. The mean duration of effect was roughly 119 days for Jeuveau compared to 107 days for Botox, a difference of about 11 days. These differences were consistent but did not reach statistical significance, meaning the two products perform similarly overall.
The biggest practical difference is price. Jeuveau runs between $8 and $20 per unit, while Botox typically costs $10 to $20 per unit. For a standard frown line treatment, that puts a Jeuveau session somewhere between $200 and $500. Dysport, another competitor, costs less per unit ($4 to $8) but requires more units per treatment because it’s dosed differently.
Manufacturing Differences
One thing that sets Jeuveau apart is how it’s made. The manufacturing process uses vacuum drying instead of freeze drying, combined with a proprietary purification method called Hi-Pure technology. This achieves at least 95 percent purity of the toxin. Vacuum drying avoids the crystal formation that can occur with freeze drying, which helps preserve the integrity of the toxin and may reduce the risk of your immune system developing antibodies against it. Antibody formation is a concern with all neurotoxins because it can make treatments less effective over time.
Side Effects and Risks
The most common side effects in clinical trials were headache, eyelid drooping, and upper respiratory symptoms. These are consistent with what’s seen across all botulinum toxin products and typically resolve on their own within days to weeks. Eyelid drooping, while uncommon, happens when the toxin migrates slightly from the injection site and affects a nearby muscle.
All botulinum toxin products carry an FDA boxed warning about the possibility of toxin spreading beyond the injection site. In theory, this could cause symptoms like difficulty swallowing, breathing problems, or generalized muscle weakness. These serious effects are extremely rare at cosmetic doses but are more of a concern at the higher doses used for medical conditions. You should not receive Jeuveau if you have a known allergy to botulinum toxin or had a reaction to any similar product in the past.
Cost and Accessibility
Because Jeuveau is a cosmetic treatment, insurance does not cover it. Total cost per session typically falls between $200 and $500 for frown lines, depending on how many units you need and where you live. Providers in major metro areas tend to charge more. Over a year, with two to four treatments needed to maintain results, the annual cost runs roughly $600 to $2,000.
Evolus markets Jeuveau through a loyalty program that can bring costs down further. It’s widely available at dermatology offices, medical spas, and plastic surgery practices across the United States. Since its launch, it has gained traction largely because of its lower price point compared to Botox while delivering comparable results.